Applied Clinical Trials Features Article on 21st Century Cures Act
January 26th, 2017
Applied Clinical Trials recently featured an article written by Michele Russell-Einhorn, JD, Vice President of Human Research Protection Services and Institutional Official at Schulman IRB, that outlines the provisions of the 21st Century Cures Act that was passed in early December. Russell-Einhorn explains how these changes will successfully preserve conscionable safeguards of safety and efficacy, eliminate undue development hurdles, and increase patient access to breakthrough treatments.
Read the full story here.